617. Deputy John Lahart asked the Minister for Health if he will give an indication of when voretigene neparvovec, Luxturna, will be added in line with the Health Act 2013 and the national framework agreed with the pharma industry in which a company must submit an application to the HSE to have a new medicine added to the reimbursement list; and if he will make a statement on the matter. [10868/22]

Summary

617. Deputy John Lahart asked the Minister for Health if he will give an indication of when voretigene neparvovec, Luxturna, will be added in line with the Health Act 2013 and the national framework agreed with the pharma industry in which a company must submit an application to the HSE to have a new medicine added to the reimbursement list; and if he will make a statement on the matter. [10868/22]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 1 March 2022

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.